peptide reconstitution FAQ

Do not attempt to remove water or add more peptide powder. The vial is now irreversibly diluted. Calculate the new concentration using the actual water volume added, then adjust your injection volume upward to maintain target dose. If the resulting injection volume exceeds 1.0mL or becomes impractical for your administration method, the vial may need to be designated for a different protocol requiring lower per-dose amounts. This is why precise measurement of bacteriostatic water before adding it to the vial is non-negotiable. Use a calibrated syringe, not estimation.

Assume the peptide may contain 10–20% less active compound than the label states and adjust your reconstitution calculations accordingly, or contact the supplier to request verification before proceeding. Research peptides without COA documentation cannot be accurately dosed because purity directly affects total active mass. Real Peptides provides amino acid sequencing and HPLC purity verification for every batch specifically to prevent this scenario. Using peptides without purity data introduces uncontrolled variables that compromise experimental reproducibility. If the research application matters, source from suppliers who verify composition.

Reduce the bacteriostatic water volume to increase concentration, allowing a larger injection volume for the same dose. For example, if the calculator suggests 0.05mL per dose, halve the bacteriostatic water volume. This doubles the concentration and doubles the injection volume to 0.1mL. Injection volumes below 0.1mL are difficult to measure accurately with standard insulin syringes and introduce significant dosing error. Most research protocols benefit from reconstituting peptides at concentrations that allow 0.2–0.5mL injection volumes, balancing measurement precision with injection site tolerance.

Change the syringe volume you draw rather than the water volume already in the vial. If your current concentration is 2mg/mL (2,000 micrograms per mL) and you're drawing 15 units (0.15mL) for 300 micrograms, increasing to 400 micrograms requires drawing 20 units instead. The peptide reconstitution calculator recalculates syringe units for the new dose using your existing concentration. This approach preserves the remaining solution and avoids introducing contaminants through additional needle punctures. Track concentration and remaining volume carefully. Once you're below 0.3mL in the vial, measurement accuracy degrades because the needle bevel cannot draw consistently from minimal fluid depth.

Reconstitute only what you'll use within 28 days and store the remainder as lyophilised powder at −20°C. Once bacteriostatic water is added, peptide stability drops. Most peptides remain potent for 28 days at 2–8°C, but degradation accelerates beyond that window even under refrigeration. The peptide reconstitution calculator helps plan partial reconstitution: if your protocol requires 250 micrograms daily and you have three 5mg vials, reconstitute one vial with 2mL (yielding 2,500 micrograms/mL), which provides 20 days of dosing at 10 units per injection. Reconstitute the second vial only when the first is depleted. This approach balances convenience against stability. You're not puncturing multiple vials (contamination risk) but you're also not storing reconstituted solution beyond its viable window.

Input 9.6mg as your peptide mass when using the peptide reconstitution calculator. The 10mg label reflects total lyophilised powder weight including stabilisers (mannitol, trehalose), but only 96% is active peptide. Using 10mg in your calculation overestimates actual dose by 4%, which seems minor until you consider a 12-week protocol. Cumulative exposure diverges enough to affect dose-response consistency. Every research-grade peptide at Real Peptides includes a Certificate of Analysis specifying purity to two decimal places; using that exact figure ensures your reconstitution math reflects what's actually in solution, not what's printed on the vial.

Recalculate injection volume based on the concentration already established when you added bacteriostatic water. If you initially reconstituted for 250mcg per 0.25mL and now need 500mcg, draw 0.5mL instead. The peptide reconstitution calculator does not need to be re-run unless you are reconstituting a new vial. The concentration remains constant once bacteriostatic water is added. Only injection volume changes with dose adjustments. This is one advantage of reconstituting at higher concentrations: you retain flexibility to dose upward without exceeding practical injection volumes.

This creates positive pressure inside the vial, which can cause solution to spray out when you next insert a needle. To fix it: swab the stopper with alcohol and allow it to dry. Insert a needle attached to an empty syringe, but don't push the plunger. Just let the positive pressure push air into the syringe barrel naturally until the vial pressure normalises. Withdraw the needle and proceed with your normal draw protocol. This isn't contamination-critical as long as you used a sterile needle and proper swabbing technique, but repeated overpressurisation stresses the vial stopper and can cause micro-tears that compromise the seal. If you're consistently adding excess air, you're likely not tracking your pressure equalisation volume correctly. Air in should equal liquid out on every single draw.

Gently swirl the vial in a circular motion for 30 seconds. Do not shake or invert. P21's glutamic acid and aspartic acid residues carry negative charges at physiological pH, which causes electrostatic repulsion between peptide molecules and slows dissolution in low-ionic-strength solvents like bacteriostatic water. If visible particles remain after swirling, place the sealed vial in a refrigerator at 2–8°C for 2–4 hours; the reduced kinetic energy at lower temperature paradoxically improves solvation by allowing peptide molecules to orient into energetically favourable configurations without clumping. Cloudiness that persists beyond 4 hours indicates irreversible aggregation. The peptide is degraded and should not be used.

First, confirm you added the correct solvent volume. Underdissolved powder usually indicates you added too little water for the peptide mass present. If your calculations were correct and powder remains, gently roll the vial between your palms for 60 seconds without shaking. The warmth from your hands slightly increases molecular kinetic energy, which speeds passive diffusion. If powder still persists after rolling, let the vial sit at room temperature for an additional 10 minutes before refrigerating. Do not use heat to accelerate dissolution. Temperatures above 25°C begin denaturing the peptide. If the powder has not dissolved after 15 minutes total, contact your peptide supplier for a replacement vial.

Replace it immediately. Bacteriostatic water's sterility guarantee depends on the 0.9% benzyl alcohol preservative, which maintains antimicrobial activity for approximately 28 days after first access. Beyond that point, benzyl alcohol concentration drops through evaporation and chemical degradation, and the water can support bacterial growth despite appearing clear. This is a hard deadline. Not a suggested guideline. Using expired bacteriostatic water to reconstitute new peptides introduces contamination risk from the start, and you won't know the vial is compromised until bacterial growth becomes visible (typically 5–7 days post-mixing). Mark your bacteriostatic water vial with the date of first needle puncture, and track it separately from the reconstituted peptide timeline.

Discard the vial if it sat at room temperature (above 8°C) for more than 4 hours. Peptides are temperature-sensitive biologics. Even short-term exposure to ambient temperature accelerates degradation through protein unfolding, and there's no reliable way to test potency loss at home. The 28-day stability window assumes continuous refrigeration at 2–8°C; a single overnight temperature excursion voids that timeline. If the vial was out for fewer than 2 hours and you're within the first week post-reconstitution, you can continue using it but consider the stability window shortened to 14 days maximum. Document the incident and monitor for any changes in solution clarity or colour. Cloudiness or yellowing indicates bacterial growth or oxidation.

Stop using the vial immediately and do not inject the solution. Visible particulates indicate one of three failures: protein aggregation from improper reconstitution technique (direct injection onto the puck, vigorous shaking), contamination (bacterial growth or environmental particulate introduction), or peptide degradation from temperature excursion or extended storage beyond the 28-day window. Protein aggregates won't dissolve with additional time or gentle swirling. The damage is irreversible. Bacterial contamination can present as white floaters, cloudiness, or a subtle colour shift to pale yellow. There's no safe way to 'rescue' a contaminated vial. Discard it in a sharps container and reconstitute a fresh peptide if your research timeline requires continuation. For researchers working with high-purity compounds like those from Real Peptides, solution clarity should remain consistent throughout the 28-day window when proper sterile technique is maintained.

Each time air is injected into a multi-dose vial, the resulting positive pressure forces liquid back through the needle bore when you withdraw the syringe. Carrying airborne contaminants from the needle hub into the solution. If this happens once, the risk is low; if it happens repeatedly over the vial's 28-day lifespan, bacterial contamination becomes likely. To avoid this, always equalise pressure by drawing air into the syringe before injecting the needle (e.g., draw 0.2mL air, inject the needle, push the air into the vial headspace, then draw your dose). If you inject air unintentionally, finish drawing your current dose but mark the vial with the contamination date. Use it within 7 days instead of the full 28-day window.

Reconstituted peptide solutions are fragile during transport. If you must move a vial after reconstituting, use an insulated medical transport cooler with ice packs that maintain 2–8°C. Standard lunch-box coolers with loose ice are insufficient. Temperature fluctuations above 8°C accelerate degradation, and temperatures near 0°C risk partial freezing. Purpose-built insulin coolers work well for short trips up to 12 hours. For longer transport, use a laboratory specimen cooler with temperature data logging. Never transport reconstituted MOTS-C in checked luggage on flights. Cargo holds can drop below freezing at altitude. If you're traveling and need peptide access, consider using pre-filled syringes drawn under sterile conditions immediately before departure.

Discard the vial immediately without injecting any solution. Cloudiness indicates protein aggregation or particulate contamination; discolouration (yellow, brown, or pink tint) indicates oxidative degradation or bacterial growth. P21 in proper solution is clear and colourless. Any deviation is a hard stop. Lyophilised peptides are hygroscopic and absorb atmospheric moisture during storage if the vial seal is compromised; this introduces water activity that allows Maillard reactions between the peptide's amino groups and trace reducing sugars in the formulation matrix, producing brown discolouration even before reconstitution. Check our full peptide collection for replacement vials with verified cold-chain handling.

Stop using that vial for research applications where peptide integrity is critical. Shaking introduces two forms of mechanical stress: turbulent flow (which disrupts hydrogen bonds in the peptide backbone) and air incorporation (which accelerates oxidation of methionine residues). MOTS-C contains two methionine residues critical for mitochondrial ribosome binding. Oxidation at these sites reduces bioactivity without any visible change to the solution. If you shook the vial within the first 30 seconds of reconstitution, the damage is limited but not negligible. For low-stakes exploratory work, you can proceed with caution. For any application where dosing precision matters, discard the vial and start over.

Reconstitute a fresh vial at the new target concentration rather than trying to dose fractional volumes from the existing vial. If your protocol shifts from 500mcg to 350mcg per injection and your current vial is mixed at 2.5mg/mL (requiring 0.14mL—an awkward volume), the cleanest solution is starting a new vial at 1.75mg/mL (2mL BAC water per 3.5mg peptide), giving you exactly 0.2mL per 350mcg dose. Attempting to draw 0.14mL consistently with a 0.3mL syringe introduces ±10–15% measurement error that compounds across multiple injections. Precision matters more than vial economy when dosing accuracy determines protocol outcomes.

Add more bacteriostatic water in 0.5mL increments until the solution clears completely—cloudiness indicates you've exceeded solubility limits for that specific peptide batch. Some lyophilized peptides, particularly those with hydrophobic amino acid sequences or bulky side chains, require more dilute concentrations than standard guidelines suggest. Dihexa commonly shows this behavior—batches that should dissolve at 5mg/mL sometimes require 3–4mg/mL to achieve complete clarity. Never force dissolution by vigorous shaking or heating; both denature peptide tertiary structure and eliminate biological activity. If dilution to 2mg/mL still leaves visible particles, the peptide batch may have degraded during storage or shipping.

It can't. Not safely. Benzyl alcohol loses antimicrobial efficacy after 28 days, and peptide degradation accelerates regardless of refrigeration or visible clarity. Freezing reconstituted peptides is not a reliable preservation method; ice crystal formation disrupts tertiary protein structure, and thawing creates aggregation that cannot be reversed. If your research protocol requires peptide availability beyond 28 days, reconstitute smaller volumes more frequently rather than preparing large batches. The 28-day window is a hard biochemical limit, not a conservative estimate.